Wilson Disease Treatment in Thailand
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Wilson Disease?
Wilson disease is a rare inherited disorder of copper metabolism caused by pathogenic variants in the ATP7B gene. The condition prevents the body from properly transporting and eliminating excess copper, causing copper to accumulate primarily in the liver and, in some patients, the brain, eyes and other organs. Wilson disease can cause liver disease, neurological or movement disorders, psychiatric symptoms and other systemic complications. It is inherited in an autosomal recessive pattern.
What is the Importance of Timely Treatment?
Timely diagnosis and lifelong treatment are important because progressive copper accumulation can cause irreversible liver and neurological damage. Early treatment can reduce copper accumulation, prevent further organ injury and help control existing symptoms. Individuals with severe liver failure or disease that does not respond adequately to medical treatment may require liver transplantation.
What are the Common Symptoms of Wilson Disease?
- Jaundice or yellowing of the skin and eyes
- Abdominal swelling or discomfort
- Fatigue and weakness
- Enlarged liver or spleen
- Abnormal liver function
- Tremors
- Muscle stiffness or dystonia
- Problems with coordination or walking
- Difficulty speaking or swallowing
- Involuntary movements
- Difficulty with handwriting or fine movements
- Mood or behavioural changes
- Depression or anxiety
- Cognitive changes
- Kayser-Fleischer rings around the cornea
- Episodes of hemolytic anemia
Causes and Risk Factors of Wilson Disease
Causes
- Wilson disease is caused by pathogenic variants in both copies of the ATP7B gene, which provides instructions for a copper-transporting protein that incorporates copper into ceruloplasmin and eliminates excess copper through bile.
- Impaired ATP7B function leads to progressive copper accumulation in tissues.
Risk Factors
- Having pathogenic variants in both copies of the ATP7B gene
- Having a sibling or close relative with Wilson disease
- Having parents who are carriers of an ATP7B pathogenic variant
- Family history of unexplained liver disease or neurological symptoms
- Consanguinity in families, which can increase the likelihood of autosomal recessive disorders
Latest Research and Technologies in the Treatment of Wilson Disease in Thailand
- Current management of Wilson disease relies on biochemical testing, genetic evaluation when appropriate, lifelong copper-lowering treatment, and regular monitoring for liver and neurological complications. Research is exploring improved biomarkers of copper accumulation, genetic and molecular mechanisms, treatment-response monitoring, and new copper-modifying therapies. Liver transplantation remains an important option for selected patients with acute liver failure or advanced liver disease that does not respond to medical treatment.
Treatment options for Wilson Disease
Liver Transplantation : Liver transplantation may be considered for patients with acute liver failure, severe decompensated liver disease or inadequate response to appropriate medical treatment.
Cost Start From 50000Explore Options
- Clinical assessment:
- Medical and Neurological Evaluation: Detailed medical and family history, along with neurological examination and assessment of liver-related symptoms and signs.
- Copper and Liver Function Testing: Serum ceruloplasmin, serum copper, 24-hour urinary copper, liver function tests, coagulation profile and complete blood count help assess copper metabolism and organ involvement.
- Eye Examination: A slit-lamp examination is performed to detect Kayser-Fleischer rings, which result from copper deposition in the cornea.
- Genetic and Hepatic Evaluation: ATP7B genetic testing can help confirm the diagnosis. Liver biopsy with quantitative hepatic copper measurement may be considered when the diagnosis remains uncertain.
- Leipzig Scoring System: The Leipzig score combines clinical findings, copper studies, Kayser-Fleischer rings and genetic results to support the overall diagnosis of Wilson disease.
- Imaging Tests:
- Abdominal Ultrasound: Helps assess liver structure, cirrhosis, portal hypertension and other liver abnormalities.
- Liver Doppler Ultrasound: Evaluates blood flow in the portal and hepatic vessels, particularly when portal hypertension is suspected.
- Brain MRI: May identify characteristic abnormalities in patients with neurological Wilson disease and can help assess the extent of neurological involvement.
- CT Scan: May be used in selected cases when additional structural information is required.
- Elastography: May help assess liver stiffness and the degree of liver fibrosis.
- Slit-Lamp Examination: Although not an imaging test of the liver, this specialised eye examination can identify Kayser-Fleischer rings caused by copper deposition.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support Wilson Disease patients in Thailand. These services include:
- Physiotherapy: Helps address muscle stiffness, tremors, balance problems, weakness and gait difficulties.
- Occupational Therapy: Supports independence in daily activities and helps patients manage coordination and fine motor challenges.
- Speech and Swallowing Therapy: May help patients with speech, communication or swallowing difficulties caused by neurological involvement.
- Neurorehabilitation: Structured rehabilitation can address movement disorders, coordination problems and other neurological limitations.
- Medical treatment for Wilson disease is lifelong and aims to reduce excess copper and prevent further accumulation. Copper-chelating medicines increase urinary copper excretion, while zinc salts reduce intestinal copper absorption and may be used in selected patients. Additional medicines may be prescribed to manage neurological, psychiatric, liver-related or other complications. Regular monitoring of liver function, blood counts, urinalysis, serum copper, and urinary copper helps assess treatment effectiveness and safety.
Instantly Connect with our Specialists
Hospitals for Wilson Disease in Thailand
Phyathai 2 International Hospital
Bangkok, Thailand
Phyathai 2 International Hospital located in Bangkok, Thailand is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
- Fully equipped rooms are available for convenience of the patients- Gold B Room, Gold A Room, Pediatric Gold A, Platinum room, and Prestige ward
- Nearby accommodations are also available- Abloom Service Apartments, Bangkok Patio, VIB Best Western Sanam Pao, VIC3 Hotel
- Operating room
- International Patient Medical Center to assist overseas patients
Bangkok Hospital
Bangkok, Thailand
Bangkok Hospital located in Bangkok, Thailand is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
- It is recognised for the application of the newest healthcare technology.
- Blood analysis center that is not just the best in Thailand but in Asia Pacific as well.
- Biomolecule center that is the seed of healthcare equipment for Thailand and overseas.
- International affiliations and collaborations with universities and hospitals in Japan and the United States of America.
- 11 hospitals are recognised as Centers of Excellence.
- Known excellence in Trauma, Orthopedics, Cardiovascular, Neurology as well as Cancer Care.
- There is a proper streamlined patient services process followed in Bangkok Dusit Medical Services, Bangkok, Thailand.
- A well developed research center showcases the intent of the organisation to provide research based treatment opportunities to the patients.
- The group has several Medical industry partnerships as well to ensure healthcare solutions.
Vejthani Hospital
Bangkok, Thailand
Vejthani Hospital located in Bangkok, Thailand is accredited by NABH, NABL. Also listed below are some of the most prominent infrastructural details:
- It is among the topmost private hospitals functioning in Thailand.
- The bed capacity of the hospital is 263.
- There are more than three hundred thousand patients visiting the hospital every year.
- Vejthani hospital has more than 40 outpatient clinics and centers.
- International patient care center with all kinds of services: air ambulance, transfers, travel, stay, embassy liaison, patient coordinators, prayer rooms, visa coordination and translators for 20 languages.
- The special facilities are:
- International Certified Laboratory
- 10 Operating Rooms
- Radiology Section: Portable X-ray, CT-scan and C-ARM and MRI
- Neonatal Critical Care Unit
- Water-jet technique applied for liposuction
- Computer navigation and mini-invasive technique for Joint Replacement surgery
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose Thailand for Wilson Disease Treatment?
- Multidisciplinary Specialist Care: Patients can access hepatologists, neurologists, gastroenterologists, genetic specialists, transplant physicians and rehabilitation professionals.
- Advanced Diagnostic Facilities: Major centres may offer copper studies, genetic testing, liver assessment, brain MRI and specialised ophthalmological evaluation.
- Comprehensive Medical Management: Specialised teams can provide long-term chelation, zinc therapy, nutritional management and monitoring of treatment response.
- Liver Transplantation Services: Selected centres provide liver transplantation for patients with acute liver failure or advanced liver disease requiring transplant evaluation.
- Rehabilitation and Long-Term Support: Physiotherapy, occupational therapy, speech therapy, nutritional care and psychological support can be integrated according to individual needs.
Frequently Asked Questions
Wilson disease requires lifelong treatment rather than a short-term recovery period. Liver-related symptoms may improve during the first months of effective treatment, while neurological symptoms can take longer to stabilise and may not completely reverse in every patient.
Many people with Wilson disease can walk normally, particularly when neurological involvement is mild or absent. More advanced disease may cause tremors, dystonia, rigidity or coordination problems that affect walking and may require physiotherapy or other rehabilitation.
Major Thai centres may provide advanced liver-function testing, copper studies, ATP7B genetic testing, brain MRI, ophthalmological assessment, liver fibrosis evaluation and specialised hepatology and neurology services.
Many major Thai hospitals have international-patient departments that can assist with medical records, specialist consultations, treatment coordination, travel arrangements, accommodation and follow-up care.
Consider a centre with experience in inherited liver and metabolic disorders and access to hepatology, neurology, genetics, nutrition and liver transplantation when required. For advanced liver disease, a centre with an experienced transplant team may be particularly important.
No single success rate applies to all patients with Wilson disease. Outcomes depend on age at diagnosis, the extent of liver or neurological involvement, treatment adherence, response to copper-lowering therapy, and whether advanced liver disease is present. Early and consistent treatment can prevent or reduce further copper-related organ damage.
Specialists, including hepatologists, gastroenterologists, neurologists, and transplant physicians, manage Wilson disease in specialised centres. Experience with inherited metabolic liver disorders and long-term copper management is important when selecting a treatment centre.
Treatment risks depend on the medicine and the patient's condition. Chelating medicines can cause adverse effects involving the blood, kidneys, gastrointestinal system or skin, while zinc can cause gastrointestinal symptoms. Neurological symptoms can occasionally worsen after starting treatment, so regular specialist monitoring is important.
Seek urgent medical care for jaundice that worsens rapidly, confusion, unusual bleeding, severe weakness, or rapidly worsening neurological symptoms. Wilson disease can cause acute liver failure, which is a medical emergency.
Wilson disease does not typically cause structural physical deformities. However, prolonged neurological involvement may lead to persistent movement difficulties, dystonia, muscle stiffness, speech problems, or impaired coordination. Early treatment and rehabilitation may help preserve or improve function, although recovery varies.
Yes. Liver disease, fatigue, movement disorders, psychiatric symptoms, and cognitive difficulties can affect work, education, relationships, and daily activities. Appropriate copper-lowering treatment, psychological support, and rehabilitation can help manage these effects and support independence.
Without treatment, copper accumulation can cause progressive liver damage, cirrhosis, portal hypertension, liver failure, neurological disability, psychiatric complications, and other organ problems. Some patients develop life-threatening acute liver failure. Lifelong treatment is necessary to prevent progression.
Wilson disease cannot be prevented in someone who has inherited disease-causing variants in both copies of the ATP7B gene. However, early diagnosis and treatment can prevent or reduce organ damage. Genetic or biochemical screening of at-risk relatives is recommended to identify affected family members and treat them early.
Wilson disease can affect people of any sex and occurs worldwide. It is inherited in an autosomal recessive pattern, meaning that a person generally needs disease-causing variants in both copies of ATP7B to develop the condition. Siblings and other relatives may be at increased risk, even when they have no symptoms or known family history of liver disease.
Reviewer
Dr. Akash Khandelwal
Hematologist
9 Years of Experience
Dr. Akash Khandelwal is a distinguished Hematologist, Hemato-oncologist, and Bone Marrow Transplant (BMT) Physician with extensive training from the prestigious AIIMS New Delhi. His expertise encompasses a wide range of specialized techniques in bone marrow transplantation, including autologous and allogeneic transplants such as matched sibling donors, matched unrelated donors (MUD), and haploidentical donor transplants. Dr. Khandelwal has personally supervised and conducted over 100 bone marrow transplants. View More
Last Reviewed - January 2026